HTGMQ.US HTG Molecular Diagnostics Inc.

Healthcare Biotechnology USA Stocks
0.0001 USD
Close of Nov 14, 2026
0.0001 0.0001
Market cap
USD 221.00
P/E
-
P/B
0.01x
ROE
-
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2023.

Is HTGMQ.US undervalued?

Graham number

The Graham number of HTG Molecular Diagnostics Inc. cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

HTG Molecular Diagnostics Inc. fundamental analysis

No fundamental analysis for HTG Molecular Diagnostics Inc. yet.

HTG Molecular Diagnostics Inc. stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About HTG Molecular Diagnostics Inc.

HTG Molecular Diagnostics, Inc. a life sciences company, focuses on the precision medicine. The company offers instruments; consumables; and software that automate sample processing and profiles various molecular targets. Its marketed molecular profiling panels include HTG Transcriptome Panel; HTG EdgeSeq precision immuno-oncology panel; HTG EdgeSeq miRNA whole-transcriptome assay; HTG EdgeSeq DLBCL cell of origin assay EU; HTG EdgeSeq Oncology Biomarker Panel; HTG immune re…

Full company profile